News

VCSCB Faculty Members Join Cardiac Stem Cell Consortium

Vanderbilt University Medical Center has been named one of the nine research hubs of the National Heart, Lung and Blood Institute Progenitor Cell Biology Consortium, a seven-year, $170 million research initiative to develop the field of stem and progenitor cell tools and therapies.

The award brings together experts from heart, lung, blood and technology research to create 18 multi-disciplinary teams of investigators whose goal is to identify and characterize progenitor cell lines, direct the differentiation of stem cells and progenitor cells to desired cell fates, and develop new clinical strategies to address the unique challenges presented by the transplantation of these cells.

Antonis Hatzopoulos, Ph.D., Scott Baldwin, M.D., and Charles Hong, M.D., Ph.D., all of whom are VCSCB faculty members, are part of the Vanderbilt research team that will be participating in the consortium.

To read the full article in today's VUMC Reporter go to:
https://www.mc.vanderbilt.edu/reporter/index.html?ID=7633.

Congratulations to our faculty members and good luck to this team of scientists!